44 2033180199

Goals for the treatment of obesity using new pharmaceuticals and non-pharmacological agents

Silverio Perrotta, Maya Buch

Type 2 diabetes, the primary metabolic complication of obesity, has become a global epidemic, necessitating the development of fresh approaches to both treating and preventing the disease. While essential for treating obesity, a good diet and regular exercise are frequently insufficient. Pharmacotherapy can help with compliance maintenance, reducing obesity-related health concerns, and enhancing quality of life. In the last two decades, there has been a tremendous improvement in our understanding of the cerebral and peripheral mechanisms driving homeostatic and hedonic aspects of food intake. Obesity may result from an imbalance in one or more of these factors.

Публикация рецензирования для ассоциаций, обществ и университетов pulsus-health-tech